Newsroom
Sorted by: Latest
-
Johnson & Johnson Announces 64th Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 3.1%
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a 3.1% increase in the quarterly dividend, from $1.30 per share to $1.34 per share, marking the 64th year of consecutive increases. At the new rate, the indicated dividend on an annual basis is $5.36 per share compared to the previous rate of $5.20 per share. The next quarterly dividend is payable on June 9, 2026 to shareholders of record at the close of business on M...
-
Johnson & Johnson reports Q1 2026 results, raises 2026 outlook
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced results for first-quarter 2026. “Johnson & Johnson had a strong start to 2026 and is delivering on its promise for a year of accelerated growth and impact,” said Joaquin Duato, Chairman and Chief Executive Officer, Johnson & Johnson. “The depth and strength of our portfolio and pipeline is unrivaled and our relentless focus on innovation delivered multiple game-changing approvals this quarter, includ...
-
CannaLnx Expands Insured Medical Cannabis Access Across California with 9 Retail and Delivery Partners
CLEVELAND--(BUSINESS WIRE)--EM2P2, the company behind the CannaLnx health care platform, today announced a major expansion across California through partnerships with nine dispensary and delivery operators representing 15 storefronts and multiple regional delivery networks. The expansion marks one of the most significant real-world implementations to date of insurance-integrated medical cannabis infrastructure—moving the model from concept to active deployment across key markets including Los A...
-
Jeito Capital leads oversubscribed $75 million Series C in Adcendo ApS to Advance its First- and Best-in-class Clinical ADC1 Pipeline in Oncology
PARIS--(BUSINESS WIRE)--Jeito Capital (“Jeito”), a leading global independent private equity fund dedicated to Biopharma, is leading an oversubscribed $75 million (€ 65 million2) Series C financing round in Adcendo ApS (“Adcendo”), a biopharma company focused on the development of first-and best-in-class antibody-drug conjugates (ADCs) for the treatment of cancers with high unmet medical need. The investment comes from Jeito Capital’s second fund, which closed on March 31, 2026 with $1.23 billi...
-
DLR Group Launches Global Infrastructure Practice
LOS ANGELES--(BUSINESS WIRE)--Global integrated design firm DLR Group has launched a new Infrastructure practice, expanding capabilities across aviation, power, and transportation....
-
Media Advisory: FHLB Dallas and First Federal Bank of Louisiana Celebrate $142K Grant to Help Louisiana Families Resolve Heirs’ Property Barriers
LAKE CHARLES, La.--(BUSINESS WIRE)--Representatives from the Federal Home Loan Bank of Dallas (FHLB Dallas) and member, First Federal Bank of Louisiana, will join Project Build a Future (PBAF) for a check presentation celebrating a $142,401 Pathway Fund grant. The grant will expand PBAF’s ability to help families resolve heirs’ property challenges, clear long‑standing title issues and protect generational wealth, giving more residents in Calcasieu Parish access to critical legal and educational...
-
Candriam UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Candriam (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of...
-
SSRP Institute Welcomes Medivive as New Trusted Partner
WILLOUGHBY, Ohio--(BUSINESS WIRE)--The SSRP Institute is pleased to announce that Medivive has joined its Trusted Partner Network following nomination and internal vetting aligned with SSRP’s mission of advancing science-first, education-driven clinical collaboration. Medivive offers an advanced approach to NAD⁺ therapy designed to support cellular energetics through sterile, clinician-prescribed formulations produced under current Good Manufacturing Practices (cGMP) and dispensed by licensed p...
-
Covista Announces AI-Powered Classroom of the Future for Healthcare Education with Google Cloud
CHICAGO--(BUSINESS WIRE)--Covista (NYSE: CVSA), America’s largest healthcare educator, today announced that the healthcare AI credentials Covista and Google Cloud launched together in October are now available to enrolled students across all five Covista institutions—and they are going further. Working in collaboration with Google Cloud, Covista is developing the AI-powered classroom of the future: a learning environment that will push education to a new level through precision learning at scal...
-
N-able Accelerates Recovery Time After Critical Events with Disaster Recovery as a Service
BURLINGTON, Mass.--(BUSINESS WIRE)--(Live from Empower) – N-able, Inc. (NYSE: NABL), a global cybersecurity company delivering business resilience, today announced the expansion of Cove Data Protection with a new co-managed Disaster Recovery as a Service (DRaaS) offering. The new capability enables organizations to rapidly recover from cyber incidents and site failures, without the cost, complexity, or risk of building and managing their own disaster recovery environments. As cyberattacks conti...